Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Planned sale Chief Legal Officer sold 5,760 shares at an average $19.95 ($114,934)
  2. 4 Open-market sale Chief Legal Officer sold 3,220 shares at an average $19.85 ($63,929)
  3. 4 Open-market sale Chief Scientific Officer sold 3,690 shares at an average $19.85 ($73,260)
  4. 4 Open-market sale Chief Financial Officer sold 2,811 shares at an average $19.85 ($55,809)
  5. 4 Planned sale Chief Legal Officer sold 5,760 shares at $19.50 ($112,295)
  6. 4 Planned sale Chief Legal Officer sold 5,760 shares at $21.73 ($125,155)
  7. 4 Planned sale Chief Legal Officer sold 3,290 shares at $25.00 ($82,250)
  8. 4 Planned sale Chief Legal Officer sold 5,760 shares at $24.28 ($139,867)
  9. 4 Planned sale Chief Financial Officer sold 3,546 shares at $24.28 ($86,083)
  10. 4 Open-market sale Chief Financial Officer sold 2,368 shares at $24.31 ($57,554)
  11. 4 Open-market sale Chief Scientific Officer sold 3,437 shares at $24.31 ($83,536)
  12. 4 Open-market sale Chief Legal Officer sold 4,182 shares at $24.31 ($101,644)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Planned sale Chief Legal Officer sold 3,290 shares at $25.00 ($82,250)
  16. 4 Planned sale Chief Legal Officer sold 5,760 shares at an average $22.23 ($128,017)
  17. 4 Planned sale Chief Legal Officer sold 9,050 shares at an average $24.94 ($225,736)
  18. 4 Planned sale Chief Legal Officer sold 9,870 shares at $25.01 ($246,843)
  19. 4 Planned sale Chief Financial Officer sold 20,000 shares at $25.22 ($504,370)
  20. 4 Planned sale Chief Financial Officer sold 3,477 shares at an average $21.45 ($74,576)

Page 5 of 14 · 274 filings